STCube

STCube Interest Coverage

The Interest Coverage Ratio of STCube (052020.KQ) as of Oct 28, 2026 is -24.76. In the previous year, Interest Coverage Ratio was -17.14 — a change of 44.47% (lower).

Interest Coverage

-24.76

YoY

44.47%

Last updated:

Interest Coverage Ratio of STCube is 2024 -24.76 . Interest Coverage Ratio of STCube was 2023 -17.14 . It decreases by 44.47% lower compared to the previous year.

The STCube Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
-36.02 KRW
Jan 1, 2018
-32.17 KRW
Jan 1, 2019
-3.99 KRW
Jan 1, 2020
-4.36 KRW
Jan 1, 2021
-59.57 KRW
Jan 1, 2022
-189.18 KRW
Jan 1, 2023
-17.14 KRW
Jan 1, 2024
-24.76 KRW
The STCube Interest Coverage history
YEARInterest CoverageYoY
-24.76+44.47%
-17.14-90.94%
-189.18+217.59%
-59.57+1,266.17%
-4.36+9.16%
-3.99-87.59%
-32.17-10.69%
-36.02+483.63%
-6.17-80.10%
-31.01—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

STCube Stock analysis

What does STCube do? STCube Inc. generates revenue through its two business segments. The IT segment distributes CCTV lenses and related components, targeting businesses requiring security solutions. The BT segment develops and licenses immunomodulatory anticancer drug therapeutic candidates, selling to pharmaceutical companies and research institutions. Both segments operate under the company's brand, leveraging its IT and biotechnology expertise. The IT segment focuses on closed-circuit television lens distribution, serving commercial and industrial clients seeking reliable security infrastructure. The BT segment's drug development and licensing activities cater to the pharmaceutical industry, providing innovative therapeutic candidates for cancer treatment. These offerings align with STCube's dual expertise in technology and biotechnology. STCube's revenue streams are derived from product distribution in the IT sector and licensing agreements in the biotechnology sector. The company's clients include businesses needing CCTV components and pharmaceutical firms interested in anticancer drug development. This dual approach allows STCube to serve distinct market segments with specialized solutions. STCube is one of the most popular companies on Eulerpool.

Frequently Asked Questions about STCube stock

Interest Coverage Ratio of STCube is -24.76 in 2024.

Interest Coverage Ratio of STCube changed from -17.14 to -24.76, representing a 44.47% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio STCube since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's STCube with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — STCube

All Key Metrics — STCube